Table 1.
Patient’s Demographics Data Among Gastric Cancer Patients and LGR5, CD133 status
| Demographics Data | LGR5 Status | P | CD133 Status | P | ||
|---|---|---|---|---|---|---|
| LGR5 (−) | LGR5 (+) | CD133 (−) | CD133 (+) | |||
| Age (year ± SD) | 55.02 ± 9.42 | 57.12 ± 10.73 | .478 | 51.23 ± 10.32 | 53.22 ± 11.43 | .561 |
| Sex [male (%)] | 95 (52.48) | 102 (46.57) | .136 | 83 (55.70) | 121 (48.20) | .218 |
| Underlying condition [n (%)] | ||||||
| HT | 15 (8.28) | 17 (7.76) | .674 | 19 (12.75) | 22 (8.76) | .086 |
| DM | 16 (8.83) | 12 (5.47) | .248 | 19 (12.75) | 26 (10.35) | .368 |
| Hyperlipidemia | 12 (6.62) | 10 (4.56) | .095 | 10 (6.71) | 21 (8.36) | .089 |
| Smoking | 29 (16.02) | 31 (14.15) | .115 | 24 (16.10) | 35 (13.94) | .197 |
| Alcohol | 15 (8.28) | 15 (6.84) | .664 | 19 (12.75) | 20 (7.96) | .066 |
| Family history of gastric cancer | 9 (4.97) | 8 (3.65) | .865 | 5 (3.35) | 9 (3.58) | .976 |
HT, hypertension; DM, diabetes mellitus. Comparisons between the groups were done by using ANOVA. *P < .05 is considered statistically significant.